TheStreet.com |
Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Minefield
TheStreet.com Here's what I'm hoping to find out: How much, if any, did sola slow dementia (improve cognition) in mild Alzheimer's patients compared to placebo? Lilly has told us there was a minimal efficacy trend (not statistically significant) favoring sola over … What you need to know about Alzheimer's Lifestyle tops drugs (again) in delaying dementia – The Globe and Mail Plaques, tangles and the mystery of Alzheimer's disease |
